Medicare Enrolled

Dr. Mala Karnani, DO

Clinical Neurophysiology Physician · Apple Valley, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
18419 HWY 18 - SUITE 1, Apple Valley, CA 92307
7609460960
In practice since 2015 (10 years)
NPI: 1245615798 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Karnani from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Karnani? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Karnani

Dr. Mala Karnani is a clinical neurophysiology physician in Apple Valley, CA, with 10 years of NPI registration. Based on federal Medicare data, Dr. Karnani performed 162 Medicare services across 108 unique beneficiaries.

Between the years covered by Open Payments, Dr. Karnani received a total of $3,758 from 39 pharmaceutical and/or device companies across 137 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in clinical neurophysiology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Karnani is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 10 years in practice ▲ 162 Medicare services $3,758 industry payments

Medicare Practice Summary

Medicare Utilization ↗
162
Medicare services
Bottom 19% in CA for clinical neurophysiology physician
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
108
Unique beneficiaries
$114
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~16 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
94 $104 $245
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
32 $124 $324
Electromyography of arm or leg muscles
A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them.
24 $82 $213
Assessment of and care planning for patient with impaired thought processing, typically 60 minutes 12 $223 $356
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$3,758
Total received (2018-2024)
Avg $537/year across 7 years
Top 45% in CA for clinical neurophysiology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
39
Companies
137
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,745 (99.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$13 (0.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$857
2023
$756
2022
$1,546
2021
$34
2020
$188
2019
$358
2018
$20

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$243
MDD US Operations, LLC
$180
UCB, Inc.
$78
Lundbeck LLC
$78
Genentech USA, Inc.
$56
PFIZER INC.
$44
SK Life Science, Inc.
$41
Amgen Inc.
$28
Eisai Inc.
$25
CATALYST PHARMACEUTICALS, INC.
$24
LivaNova USA, Inc.
$18
Lilly USA, LLC
$15
Alexion Pharmaceuticals, Inc.
$14
Kyowa Kirin, Inc.
$13
Top 3 companies account for 58.5% of 2024 payments
All-time payments by company (2018-2024) ›
LivaNova USA, Inc.
$931
ABBVIE INC.
$409
Genentech USA, Inc.
$311
Teva Pharmaceuticals USA, Inc.
$249
Biogen, Inc.
$210
MDD US Operations, LLC
$194
UCB, Inc.
$176
Allergan Inc.
$123
Lundbeck LLC
$114
Grifols USA, LLC
$113
SK Life Science, Inc.
$100
Amgen Inc.
$76
Janssen Biotech, Inc.
$58
Alexion Pharmaceuticals, Inc.
$53
Harmony Biosciences LLC
$49
Neurocrine Biosciences, Inc.
$47
Takeda Pharmaceuticals U.S.A., Inc.
$46
Biohaven Pharmaceutical Holding Company Ltd.
$46
PFIZER INC.
$44
Janssen Pharmaceuticals, Inc
$37
Acorda Therapeutics, Inc
$32
Amneal Pharmaceuticals LLC
$31
Mallinckrodt Hospital Products Inc.
$26
Celgene Corporation
$26
Eisai Inc.
$25
Novartis Pharmaceuticals Corporation
$24
CATALYST PHARMACEUTICALS, INC.
$24
Akcea Therapeutics, Inc.
$23
EMD Serono, Inc.
$20
Adamas Pharmaceuticals, Inc.
$19
ACADIA Pharmaceuticals Inc
$19
Otsuka America Pharmaceutical, Inc.
$17
ARGENX US, INC.
$16
MITSUBISHI TANABE PHARMA AMERICA, INC.
$15
Lilly USA, LLC
$15
Horizon Therapeutics plc
$13
Kyowa Kirin, Inc.
$13
IMPEL PHARMACEUTICALS INC.
$12
Travere Therapeutics, Inc.
$1
Top 3 companies account for 43.9% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · APOKYN · AUSTEDO · Actemra · Activase · Aimovig · Apokyn · Austedo XR · BOTOX · Briviact · Cholbam · DUOPA · Enspryng · FYCOMPA · Fintepla · GAMMAGARD · GOCOVRI · Gamunex-C · Gocovri · INBRIJA · KESIMPTA · KISUNLA · Leqembi · MAVENCLAD · NUEDEXTA · NUPLAZID · NURTEC ODT · Nourianz · OCREVUS · Ocrevus · Ongentys · Ponvory · QULIPTA · RADICAVA · REXULTI · RYTARY · TECFIDERA · TEGSEDI · TREMFYA · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VNS Therapy SenTiva Model 1000 Generator · VYEPTI · VYVGART · Wakix · ZEPOSIA · Zilbrysq
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a clinical neurophysiology physician in Apple Valley?
Compare clinical neurophysiology physicians in the Apple Valley area by procedure volume, costs, and industry payment transparency.
Browse clinical neurophysiology physicians nearby

Geographic Context

Clinical neurophysiology physicians within 10 mi
1
Per 100K population
0.0
County median income
$82,184
Nearest hospital
PROVIDENCE ST MARY MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Karnani is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Karnani experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Karnani performed 94 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Karnani receive payments from pharmaceutical companies?
Yes. Dr. Karnani received a total of $3,758 from 39 companies across 137 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Karnani's costs compare to other clinical neurophysiology physicians in Apple Valley?
Dr. Karnani's average Medicare payment per service is $114. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Karnani) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →